Literature DB >> 18303386

Deep sclerectomy with SkGel implant: 5-year results.

Fernando Galassi1, Barbara Giambene.   

Abstract

PURPOSE: To evaluate the results of deep sclerectomy with SkGel at 3 and 5 years.
MATERIALS AND METHODS: This retrospective trial comprised 200 eyes with open angle glaucoma having a 3-year follow-up, 97 having a 5-year follow-up. Visual acuity, intraocular pressure (IOP), and slit-lamp examination were recorded at baseline and at follow-up visits. Visual field (VF) testing was repeated every 6 months.
RESULTS: Mean IOP decreased from 21.01+/-5.56 mm Hg before surgery to 13.13+/-2.24 mm Hg at 36 months and from 20.61+/-5.50 to 12.85+/-1.84 mm Hg at 60 months (P<0.0005). At 3 and 5 years, complete success rates (IOP<or=16 mm Hg without medications) were 67.50% and 64.95%, partial success rates were (IOP<or=16 mm Hg with medications) 21.50% and 24.74%, and failure rates were (IOP>16 mm Hg) 11% and 10.31%, respectively. VF testing revealed stable mean deviation and corrected pattern standard deviation values at 3 and 5 years (P>0.05). At 3 years, success rate was greater if goniopuncture was performed within 3 months after surgery (P=0.022). Complications of the surgery were not observed after goniopunctures.
CONCLUSIONS: Deep sclerectomy with SkGel provides stable control of IOP and VF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303386     DOI: 10.1097/IJG.0b013e3180d0a885

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  10 in total

1.  IOP-lowering effects for the application of human umbilical vein in non-penetrating deep sclerostomy in rabbits.

Authors:  Yang Yang; Yu Di; Dong-Mei Gui; Zhi-Li Liu; Xin Liu; Dian-Wen Gao
Journal:  Int J Ophthalmol       Date:  2011-02-18       Impact factor: 1.779

2.  Three-year canaloplasty outcomes for the treatment of open-angle glaucoma: European study results.

Authors:  Holger Bull; Kurt von Wolff; Norbert Körber; Manfred Tetz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-06       Impact factor: 3.117

3.  Deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia.

Authors:  N Anand; D Wechsler
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

4.  A modified deep sclerectomy with or without external trabeculectomy: a comparative study.

Authors:  George Kitsos; Miltiades Aspiotis; Yannis Alamanos; Konstantinos Psilas
Journal:  Clin Ophthalmol       Date:  2010-06-24

5.  Results of a modified non-penetrating deep sclerectomy in the treatment of open angle glaucoma with or without cataract.

Authors:  George Kitsos; Miltiades Aspiotis; Yannis Alamanos; Konstantinos Psilas
Journal:  Clin Ophthalmol       Date:  2010-07-30

6.  Nonpenetrating very deep sclerectomy with hyaluronic acid implant vs trabeculectomy--a 2-year follow-up.

Authors:  Rafał Leszczyński; Maria Formińska-Kapuścik; Beata Bubała-Stachowicz; Ewa Mrukwa-Kominek; Erita Filipek; Krzysztof Pawlicki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-09       Impact factor: 3.117

7.  Long-term outcomes of needle revision of failing deep sclerectomy blebs.

Authors:  Antigoni Koukkoulli; Fayyaz Musa; Nitin Anand
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-11       Impact factor: 3.117

8.  Prolene Canalostenting in Deep Sclerectomy: A Pilot Study.

Authors:  Ahmed Mostafa Abdelrahman; Yasmine Mohamed El-Sayed
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Oct-Dec

9.  Viscocanalostomy and combined phacoemulsification with viscocanalostomy: A five-year follow-up.

Authors:  Conor M Lyons; Daniela Oehring; Divya Mathews
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

10.  The CLASS Surgical Site Characteristics in a Clinical Grading Scale and Anterior Segment Optical Coherence Tomography: A One-Year Follow-Up.

Authors:  Judyta Jankowska-Szmul; Edward Wylegala
Journal:  J Healthc Eng       Date:  2018-05-15       Impact factor: 2.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.